Gallery
Picture 1
Nmtc stock forecast aligns with sector P/E expansion
SHOEBACCA
(453247)
US $286.00
List
price US
$732.000 (20%
off)
New with box
This
item is brand new and has
never been used. It still
has the original tags and/or
original packaging.
777
sold
-
Buy It NowNmtc stock forecast aligns with sector P/E expansion
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
NMTC stock forecast aligns with sector P/E expansion trends seen in Q2 See our latest analysis for NeuroOne Medical Technologies West Pharmaceutical reported second-quarter 2025 adjusted EPS of $1.84, beating the Zacks Consensus Estimate by 21.9%. Revenues of $766.5 million surpassed the Zacks Consensus Estimate by 5.4%. It currently flaunts a Zacks Rank #1. Analyst sentiment surveys put NMTC stock forecast probability of outperformance at 62% over the next three months. Catalysts include regulatory approvals in targeted expansion regions.